Поради потенциала на Transfusion Associated Graft Vesrus Host Disease (TAGVHD) се препоръчва пациентите, които са били лекувани с MabCampath, да получават облъчени кръвни продукти.
Because of the potential for Transfusion Associated Graft Versus Host Disease (TAGVHD) it is recommended that patients who have been treated with MabCampath receive irradiated blood products.